Endocrine studies in an arrhenoblastoma responsive to dexamethasone, ACTH and human chorionic gonadotropin.
D015068:17-Ketosteroids / Q000652:urine; D000311:Adrenal Glands / Q000187:drug effects; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D000328:Adult; D000738:Androsterone / Q000097:blood; D006063:Chorionic Gonadotropin / Q000494:pharmacology*; D003907:Dexamethasone / Q000494:pharmacology*; D005043:Etiocholanolone / Q000097:blood; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000503:physiopathology* / Q000601:surgery; D010053:Ovary / Q000187:drug effects; D009384:Paraneoplastic Endocrine Syndromes; D018310:Sertoli-Leydig Cell Tumor / Q000503:physiopathology* / Q000601:surgery; D013739:Testosterone / Q000097:blood / Q000378:metabolism*; D014770:Virilism / Q000209:etiology
D015068:17-Ketosteroids; D006063:Chorionic Gonadotropin; D013739:Testosterone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D005043:Etiocholanolone; D000738:Androsterone